Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Urotech Co. Ltd. has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This matter is being processed in 1 distinct art unit, indicating a specific technical focus for the company's current patent activities. The prosecution involves 1 distinct examiner, LIN, JERRY, who is handling the pending work. This concentration in 1 distinct art unit allows for a specialized legal approach tailored to the specific technical standards of that division.
LIN, JERRY is the busiest examiner for this portfolio, managing 1 pending office action. As there is only 1 pending office action in total, this examiner is the sole point of contact for the company's current pending matters. The concentration under 1 distinct examiner simplifies the prosecution landscape. Practitioners can focus their resources on the specific examination style and technical requirements of LIN, JERRY to move the application toward a final resolution.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LIN, JERRY | 1 | 72.2% | +14.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18115223 | METHOD OF CALCULATING DIAGNOSTIC SCORE FOR PROSTATE CANCER AND USE THEREOF | LIN, JERRY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18115223 | METHOD OF CALCULATING DIAGNOSTIC SCORE FOR PROSTATE CANCER AND USE THEREOF | LIN, JERRY | — |
| Art Unit | Apps |
|---|---|
| 1671 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18115223 | METHOD OF CALCULATING DIAGNOSTIC SCORE FOR PROSTATE CANCER AND USE THEREOF | LIN, JERRY | 1671 | §101DP | Non-Final OA | — | Pending | Feb 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUrotech Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jerry Lin has the most, with 1 of Urotech Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
